Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
57
LGND Quote, Financials, Valuation and Earnings
Last price:
$197.40
Seasonality move
:
6.01%
Day range:
$194.44 - $197.62
52-week range:
$93.58 - $212.49
Dividend yield:
0%
P/E ratio:
94.88x
P/S ratio:
15.44x
P/B ratio:
4.08x
Volume:
74.5K
Avg. volume:
224.6K
1-year change:
73.88%
Market cap:
$3.9B
Revenue:
$167.1M
EPS (TTM):
$2.08
Earnings Data
Next earnings date for LGND
Feb 26
2026
Most recent earnings per share
$5.68
Beat by $3.76
(Nov 6/2025)
Consensus Estimate
$1.93
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LGND Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $55.6M | -- | -- | $1.50 | -- |
| 11/06/2025 | Q3 | $58.8M | $115.5M | $5.68 | $1.93 | $3.76 |
| 08/07/2025 | Q2 | $43.9M | $47.6M | $0.24 | $1.42 | -$1.18 |
| 05/06/2025 | Q1 | $37.8M | $45.3M | -$2.21 | $1.21 | -$3.42 |
| 02/27/2025 | Q4 | $39M | $42.8M | -$1.64 | $1.19 | -$2.83 |
| 11/07/2024 | Q3 | $40.6M | $51.8M | -$0.39 | $1.35 | -$1.74 |
| 08/06/2024 | Q2 | $34.3M | $41.5M | -$2.88 | $1.06 | -$3.94 |
| 05/07/2024 | Q1 | $27.9M | $31M | $4.75 | $0.83 | $3.92 |
| 02/27/2024 | Q4 | $25.6M | $28.1M | $1.03 | $0.66 | $0.37 |
| 11/08/2023 | Q3 | -- | $32.9M | -$0.59 | -- | -- |
| 08/08/2023 | Q2 | -- | $26.4M | $0.13 | -- | -- |
| 05/04/2023 | Q1 | -- | $44M | $2.33 | -- | -- |
| 02/22/2023 | Q4 | -- | $50.4M | -$1.04 | -- | -- |
| 11/07/2022 | Q3 | -- | $59.2M | $0.02 | -- | -- |
| 08/08/2022 | Q2 | -- | $50.1M | -$0.05 | -- | -- |
| 05/04/2022 | Q1 | -- | $36.5M | -$0.91 | -- | -- |
| 02/17/2022 | Q4 | -- | $56.4M | -$0.32 | -- | -- |
| 11/09/2021 | Q3 | -- | $64.8M | $0.80 | -- | -- |
| 07/29/2021 | Q2 | -- | $84.7M | $1.79 | -- | -- |
| 05/03/2021 | Q1 | -- | $55.2M | $1.05 | -- | -- |
| 02/03/2021 | Q4 | -- | $70M | $0.35 | -- | -- |
| 10/30/2020 | Q3 | -- | $41.8M | -$0.42 | -- | -- |
| 08/03/2020 | Q2 | -- | $41.4M | $1.32 | -- | -- |
| 05/06/2020 | Q1 | -- | $33.2M | -$1.46 | -- | -- |
| 02/06/2020 | Q4 | -- | $27M | -$0.43 | -- | -- |
| 11/05/2019 | Q3 | -- | $24.8M | -$0.81 | -- | -- |
| 07/30/2019 | Q2 | -- | $25M | -$0.74 | -- | -- |
| 05/02/2019 | Q1 | -- | $43.5M | $31.32 | -- | -- |
| 02/07/2019 | Q4 | -- | $59.6M | -$2.02 | -- | -- |
| 11/08/2018 | Q3 | -- | $45.7M | $2.80 | -- | -- |
| 08/06/2018 | Q2 | -- | $90M | $2.99 | -- | -- |
| 05/08/2018 | Q1 | -- | $56.2M | $1.83 | -- | -- |
| 02/21/2018 | Q4 | -- | $50.5M | -$0.33 | -- | -- |
| 11/09/2017 | Q3 | -- | $33.4M | $0.36 | -- | -- |
| 08/07/2017 | Q2 | -- | $28M | $0.26 | -- | -- |
| 05/09/2017 | Q1 | -- | $29.3M | $0.22 | -- | -- |
| 02/23/2017 | Q4 | -- | $38.2M | -$0.15 | -- | -- |
| 11/03/2016 | Q3 | -- | $21.6M | $0.05 | -- | -- |
| 08/04/2016 | Q2 | -- | $19.5M | -$0.30 | -- | -- |
| 05/04/2016 | Q1 | -- | $29.6M | $0.26 | -- | -- |
| 02/10/2016 | Q4 | -- | $21.2M | $0.29 | -- | -- |
Ligand Pharmaceuticals, Inc. Earnings Questions
-
How Much did Ligand Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Ligand Pharmaceuticals, Inc. reported $115.5M worth of top line sales in its most recent quarter.
-
Did Ligand Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Ligand Pharmaceuticals, Inc. announced earnings per share of $5.68 which represents a beat of analyst forecast a $1.93 per share.
-
Is Ligand Pharmaceuticals, Inc. Profitable?
Ligand Pharmaceuticals, Inc. reported $103.6M that represents $5.02 per share over the last quarter.
-
What is the Analyst Consensus for Ligand Pharmaceuticals, Inc. EPS Next Year?
Ligand Pharmaceuticals, Inc.'s earnings are forecast to grow from -$0.22 per share to $5.66 per share next year representing an increase of 92.57%.
-
When is Ligand Pharmaceuticals, Inc.'s Earnings Date?
Ligand Pharmaceuticals, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
